Background: Human immunodeficiency virus (HIV) infection accelerates the progression of liver disease in Hepatitis C virus (HCV) co-infected individuals, raising the question of how immune status in co-infected individuals affects HCV quasispecies populations. We hypothesize that the structure and evolution of HCV populations in individuals with immune reconstitution differ from that in those with immune decline in HCV-HIV co-infections.
Methods: To precisely define and quantify individual HCV variants, we developed a single-variant sequencing (SVS) approach by combining random nucleotide tagging with an optimized Illumina MiSeq deep sequencing strategy. We applied this method to examine HCV quasispecies structure and evolution in envelope and NS3 genes in HCV-HIV co-infected subjects, and assess the abundance and dynamics of naturally occurring drug resistant mutations (DRMs) in NS3.
Results: We sequenced 35 serum samples collected across 10 years of follow-up from 6 HCV-HIV co-infected subjects. Three subjects who received ART early during follow-up experienced immune reconstitution. The other three subjects showed a gradual decline in CD4 count with delayed ART. A total of >16 million paired-end reads were generated to build 92,226 SVS consensus sequences based on unique sequence tags. Each consensus sequence represents an individual HCV variant. We showed that the SVS approach (1) corrected PCR/sequencing errors as well as resampling and amplification bias from PCR, and (2) provided an accurate representation of HCV population structure in vivo. Rapid non-synonymous sequence evolution was observed in hypervariable region 1 (HVR1) of E2, but not NS3, in subjects with immune reconstitution compared to subjects with immune decline. Notably, using SVS consensus, a naturally occurring DRM in NS3, aaVI170T, was detected as a minor variant (<1%) in 4 of 6 subjects over multiple visits. In contrast, an even distribution of minor DRMs across all DRM sites was observed based on raw reads (P<10-32).
Conclusions: Single-Variant Sequencing accurately defines HCV quasispecies population structure and evolution in vivo. Immune reconstitution in HIV/HCV co-infection is associated with rapid sequence evolution in the envelope but not NS3, likely driven by increased immune pressure from enhanced humoral responses during antiretroviral therapy. Drug resistant mutations in NS3 can occur naturally at low frequencies in HCV-HIV co-infected individuals, which can be accurately identified and quantified using SVS.